Modern Chinese Medicine Group Co. Ltd. (HK:1643) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Modern Chinese Medicine Group Co., Ltd. is set to unwind its contractual arrangements and increase its direct ownership in the Chinese market, following the lifting of restrictions on foreign investments in traditional Chinese medicine. This strategic move aligns with the recent changes in the 2024 Catalogue by the National Development and Reform Commission, allowing greater foreign participation in the manufacturing sector. The company anticipates completing the necessary reporting by the second half of 2026.
For further insights into HK:1643 stock, check out TipRanks’ Stock Analysis page.